I-Tyza SB 100 Capsule contains Itraconazole 100 mg, a broad-spectrum triazole antifungal agent used for the treatment of various fungal infections. Itraconazole acts by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This medication is indicated for the management of systemic and superficial mycoses, including aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and candidiasis. I-Tyza SB 100 Capsule is typically administered orally and should be taken with food to enhance absorption. The dosage and duration of therapy depend on the severity and type of infection, as well as patient response. It is important to monitor liver function during prolonged therapy due to potential hepatotoxicity. Common adverse effects include gastrointestinal disturbances such as nausea, vomiting, and abdominal pain, as well as headache and dizziness. Caution is advised in patients with hepatic impairment or congestive heart failure. Itraconazole may interact with several drugs metabolized by the cytochrome P450 system; therefore, concomitant use with certain medications requires careful consideration. I-Tyza SB 100 Capsule should be used under medical supervision to ensure efficacy and safety.